Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Similar to seemingly maladaptive genes in general, the persistence of inherited cancer-causing mutant alleles in populations remains a challenging question for evolutionary biologists. In addition to traditional explanations such as senescence or antagonistic pleiotropy, here we put forward a new hypothesis to explain the retention of oncogenic mutations. We propose that although natural defenses evolve to prevent neoplasm formation and progression thus increasing organismal fitness, they also conceal the effects of cancer-causing mutant alleles on fitness and concomitantly protect inherited ones from purging by purifying selection. We also argue for the importance of the ecological contexts experienced by individuals and/or species. These contexts determine the locally predominant fitness-reducing risks, and hence can aid the prediction of how natural selection will influence cancer outcomes.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/evo.12809 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
KSHV ORF20 Promotes Coordinated Lytic Reactivation for Increased Infectious Particle Production.
Viruses
September 2024
The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan 5290002, Israel.
Article Synopsis
- - KSHV is a cancer-causing virus linked to Kaposi's sarcoma and other rare blood cancers, and this study investigates the role of a specific protein, ORF20, in its lifecycle.
- - Researchers created a virus that lacks the ORF20 gene (ORF20-Null KSHV) and found that this mutant virus resulted in faster viral gene expression but ultimately led to cell death and decreased viral production upon reactivation.
- - The study highlights that reinstating the short form of ORF20 could restore viral production and reduce cell death, suggesting ORF20's role in enhancing viral reactivation and potential infectious particle production through its endonuclease function.
Prediction of the most deleterious non-synonymous SNPs in the human IL1B gene: evidence from bioinformatics analyses.
BMC Genom Data
June 2024
Department of Bioinformatics, Africa City of Technology, Khartoum, Sudan.
Background: Polymorphisms in IL1B play a significant role in depression, multiple inflammatory-associated disorders, and susceptibility to infection. Functional non-synonymous SNPs (nsSNPs) result in changes in the encoded amino acids, potentially leading to structural and functional alterations in the mutant proteins. So far, most genetic studies have concentrated on SNPs located in the IL1B promoter region, without addressing nsSNPs and their association with multifactorial diseases.
View Article and Find Full Text PDFBrefeldin A and M-COPA block the export of RTKs from the endoplasmic reticulum via simultaneous inactivation of ARF1, ARF4, and ARF5.
J Biol Chem
June 2024
Laboratory of Intracellular Traffic & Oncology, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan. Electronic address:
Normal receptor tyrosine kinases (RTKs) need to reach the plasma membrane (PM) for ligand-induced activation, whereas its cancer-causing mutants can be activated before reaching the PM in organelles, such as the Golgi/trans-Golgi network (TGN). Inhibitors of protein export from the endoplasmic reticulum (ER), such as brefeldin A (BFA) and 2-methylcoprophilinamide (M-COPA), can suppress the activation of mutant RTKs in cancer cells, suggesting that RTK mutants cannot initiate signaling in the ER. BFA and M-COPA block the function of ADP-ribosylation factors (ARFs) that play a crucial role in ER-Golgi protein trafficking.
View Article and Find Full Text PDFGluing GAP to RAS Mutants: A New Approach to an Old Problem in Cancer Drug Development.
Int J Mol Sci
February 2024
Department of Computer Science, Mathematical Institute, Eötvös Loránd University, 1117 Budapest, Hungary.
Mutated genes may lead to cancer development in numerous tissues. While more than 600 cancer-causing genes are known today, some of the most widespread mutations are connected to the RAS gene; RAS mutations are found in approximately 25% of all human tumors. Specifically, KRAS mutations are involved in the three most lethal cancers in the U.
View Article and Find Full Text PDFTP53 to mediate immune escape in tumor microenvironment: an overview of the research progress.
Mol Biol Rep
January 2024
The First Clinical Medical College of Lanzhou University, Lanzhou, 730000, Gansu, People's Republic of China.
Increasing evidence suggests that key cancer-causing driver genes continue to exert a sustained influence on the tumor microenvironment (TME), highlighting the importance of immunotherapeutic targeting of gene mutations in governing tumor progression. TP53 is a prominent tumor suppressor that encodes the p53 protein, which controls the initiation and progression of different tumor types. Wild-type p53 maintains cell homeostasis and genomic instability through complex pathways, and mutant p53 (Mut p53) promotes tumor occurrence and development by regulating the TME.
View Article and Find Full Text PDF